BIOCHEMICAL INTERACTIONS BETWEEN N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (FU)

被引：0
|
作者：
LIANG, CM [1 ]
DONEHOWER, RC [1 ]
ERLICHMAN, C [1 ]
CHABNER, BA [1 ]
机构：
[1] NIH,BETHESDA,MD 20205
来源：
FEDERATION PROCEEDINGS | 1980年 / 39卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1909 / 1909
页数：1
相关论文
共 50 条
  • [41] CHARACTERIZATION OF CARBAMYL-PHOSPHATE PHOSPHATASE-ACTIVITY AND ITS POSSIBLE ROLE IN N-(PHOSPHONACETYL)-L-ASPARTATE, (PALA), TREATMENT
    BLACK, MJ
    JONES, ME
    FEDERATION PROCEEDINGS, 1983, 42 (07) : 1966 - 1966
  • [42] PERIPHERAL LEUKOCYTES AS INDICATORS OF THE ENZYMATIC EFFECTS OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) ON HUMAN L-ASPARTATE TRANSCARBAMOYLASE (ATCASE) ACTIVITY
    KENSLER, TW
    ERLICHMAN, C
    JAYARAM, HN
    TYAGI, AK
    ARDALAN, B
    COONEY, DA
    CANCER TREATMENT REPORTS, 1980, 64 (8-9): : 967 - 973
  • [43] BIOCHEMICAL-MECHANISMS FOR THE SYNERGISM OF 5-FLUOROURACIL (5-FU) AND PHOSPHONOACETYL-L-ASPARTATE (PALA) IN HUMAN MAMMARY-CARCINOMA CELLS
    ARDALAN, B
    GLAZER, R
    KENSLER, T
    JAYARAM, H
    COONEY, D
    MACDONALD, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 8 - 8
  • [44] N-(PHOSPHONOACETYL)-L-ASPARTATE (PALA) CONCENTRATION AND ASPARTATE CARBAMOYLTRANSFERASE (ACTASE) ACTIVITY IN BIOPSY SPECIMENS OF PATIENTS TREATED WITH PALA
    MOORE, EC
    FRIEDMAN, J
    VALDIVIESO, M
    MARTI, JR
    RUSS, J
    LOO, TL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 221 - 221
  • [45] N-(PHOSPHONACETYL)-L-ASPARTATE SYNERGISTICALLY ENHANCES THE CYTOTOXICITY OF 5-FLUOROURACIL INTERFERON-ALPHA-2A AGAINST HUMAN COLON-CANCER CELL-LINES
    WADLER, S
    MAO, X
    BAJAJ, R
    HALLAM, S
    SCHWARTZ, EL
    MOLECULAR PHARMACOLOGY, 1993, 44 (05) : 1070 - 1076
  • [46] STRUCTURE AT 2.9-A RESOLUTION OF ASPARTATE CARBAMOYLTRANSFERASE COMPLEXED WITH THE BISUBSTRATE ANALOG N-(PHOSPHONACETYL)-L-ASPARTATE
    KRAUSE, KL
    VOLZ, KW
    LIPSCOMB, WN
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (06) : 1643 - 1647
  • [47] PRE-CLINICAL PHARMACOLOGY OF N-(PHOSPHONACETYL)-L-ASPARTATE IN DOGS, MONKEYS, AND RATS
    STOUT, LD
    CUSIC, AM
    DENINE, EP
    HARRISON, SD
    PHARMACOLOGIST, 1978, 20 (03): : 191 - 191
  • [48] HEPATOTOXICITY OF FLUOROURACIL WITH N-PHOSPHONACETYL-L-ASPARTATE
    STENRAM, U
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (01) : 90 - 91
  • [49] PHASE-1 AND CLINICAL PHARMACOLOGICAL EVALUATION OF BIOCHEMICAL MODULATION OF 5-FLUOROURACIL WITH N-(PHOSPHONACETYL)-L-ASPARTIC ACID
    CASPER, ES
    VALE, K
    WILLIAMS, LJ
    MARTIN, DS
    YOUNG, CW
    CANCER RESEARCH, 1983, 43 (05) : 2324 - 2329
  • [50] N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II TRIAL OF THE EORTC MALIGNANT-MELANOMA COOPERATIVE GROUP
    KLEEBERG, UR
    MULDER, JH
    RUMKE, P
    THOMAS, D
    ROZENCWEIG, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (08): : 723 - 726
12345